Posted Mar. 18, 2014 at 9:54 a.m.

Premium Lock BioKier signs deal on 'late-blooming' drug delivery

Published: 2014-03-18 09:54:43
Updated: 2014-03-18 09:54:43


The Chapel Hill-based company has received early funding and other help from the North Carolina Biotechnology Center in its quest to develop a novel treatment for type 2 diabetes that also potentially could have effects in metabolic syndrome and obesity....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2017 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Latest for Insiders